UT Health San Antonio Virtual Campus Tour
Are you a prospective student who would like to know what the UT Health San Antonio campus looks like? Now, you can!
Commencement
Logins
Resources
- COVID-19 Updates for Students
- Enrolled Student Resources
- Office of Career Development Resource Guide
- Virtual Course Instruction
Featured Events
Cancer Biology
A discipline of Ph.D. in Integrated Biomedical Sciences
The Cancer Biology discipline is a vibrant community of successful researchers and educators with expertise across the spectrum of bench research to bedside application. The Cancer Biology discipline provides students and fellows rigorous training in fundamentals of cancer biology and translational aspects of cancer research including drug development, prevention and treatment. Our National Cancer Institute (NCI) designed cancer center provides students the opportunity to closely interact with physician scientists. We have Cancer Prevention and Research Institute of Texas and NCI T32 training grants. In addition, our students successfully compete in NCI pre-doctoral fellowships; publish in high impact journals and pursue successful careers at top-tier academic institutes and industries.
Program at a glance
Cancer Biology is a discipline of the Ph.D. in Integrated Biomedical Sciences program.
Requirements
- Bachelor's degree or a Master's degree and relevant advance coursework
- GPA no lower than 3.0
- Submit transcripts to Office of the Registrar
Application Deadlines
- Priority January 1
- Final March 15
Stipend
Students receive a stipend of $30,000. Tuition, fees, and basic student health insurance are covered by the program.
Characteristics
Graduation, student, faculty and institutional statistics for the Integrated Biomedical Sciences Graduate Program.
Contact information
Janet Correa, Cancer Biology Discipline Coordinator
210-567-3902">210-567-3902
correarjg@uthscsa.edu
For IBMS Ph.D. information, please contact:
Angela Watts, Assistant Director of Academic Programs
"I chose the Cancer Biology discipline because of the interdisciplinary and collaborative environment which fosters innovative translational approaches to improve cancer patient outcomes and survivorship."Kristin Altwegg, 2nd year student